Standard Biotools (LAB) Amortizatization of Intangibles (2010 - 2026)
Standard Biotools (LAB) reported Amortizatization of Intangibles of $632000.0 for Q1 2026, down 56.05% year-over-year from $1.4 million in Q1 2025, and down 31.97% quarter-over-quarter from $929000.0 in Q4 2025.
Standard Biotools (LAB) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has 16 years of Amortizatization of Intangibles data on file, last reported at $632000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $632000.0, down 56.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (down 50.03% YoY), and the FY2025 annual result was $2.6 million, down 39.16% from the prior year.
- Amortizatization of Intangibles retreated to $632000.0 in Q1 2026 per LAB's latest filing, from $929000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $5.4 million in Q2 2023 and troughed at -$1.2 million in Q3 2025.
- A 5-year average of $1.6 million and a median of $1.4 million in 2025 frame the typical range for Amortizatization of Intangibles.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 1176.36% in 2024 and fell as far as 136.11% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at $3.0 million in 2022, then dropped by 5.66% to $2.8 million in 2023, then tumbled by 70.96% to $813000.0 in 2024, then grew by 14.27% to $929000.0 in 2025, then tumbled by 31.97% to $632000.0 in 2026.
- Business Quant data shows LAB's Amortizatization of Intangibles at $632000.0 in Q1 2026, $929000.0 in Q4 2025, and -$1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 422.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 180.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 6.50 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 75.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Standard Biotools | 344.96 Mn | -110.22 Mn | 11.31 Mn | 632,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 632,000.00 |
| Mar 31, 2026 | 632,000.00 |
| Dec 31, 2025 | 929,000.00 |
| Dec 31, 2025 | 929,000.00 |
| Sep 30, 2025 | -1.15 Mn |
| Sep 30, 2025 | -1.15 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | 813,000.00 |
| Dec 31, 2024 | 813,000.00 |
| Sep 30, 2024 | -1.01 Mn |
| Sep 30, 2024 | -1.01 Mn |
| Jun 30, 2024 | 2.44 Mn |
| Jun 30, 2024 | 2.44 Mn |
| Mar 31, 2024 | 2.11 Mn |
| Mar 31, 2024 | 2.11 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Dec 31, 2023 | 2.80 Mn |